ARTICLE | Company News
Amarantus BioSciences, Generex deal
August 15, 2011 7:00 AM UTC
The companies will use Amarantus' PhenoGuard cell immortalization process to develop beta cell replacement therapies to aid diabetes therapy. This is the third diabetes research collaboration between ...